Molly Harper, Director at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 53,492 shares at $23.73 ($1.2M) on 2025-12-12, disclosed to the SEC on 2025-12-16.
Open-market sale of $1.2M CPRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.06 | 6,746 | $156K | 12.5% |
| 2 | $23.06 | 6,746 | $156K | 12.5% |
| 3 | $23.20 | 15,527 | $360K | 29.0% |
| 4 | $23.20 | 15,527 | $360K | 29.0% |
| 5 | $23.73 | 4,473 | $106K | 8.5% |
| 6 | $23.73 | 4,473 |
| $106K |
| 8.5% |
| Total | $23.25 avg | 53,492 | $1.2M | 100% |
| Filing → |
| CPRX | SELL | 2023-12-19 | $201K | — | Filing → |